Blue Flower



The documentations contained in this archive section are provided for historical purposes only. The information contained in each documentation is accurate only as of the date each documentation was originally issued. NOXXON disavows any obligation to update the information contained in such documentations after the date of their issuance.

2017, July 11 - NOXXON Pharma NV Prospectus approved 10 July 2017

Overview and Characteristics of the Notes and Warrants of the financing agreement signed on May 01, 2017
2017, September 18 - Updated Summary Table of ODIRNANE & BSA
2017, May 02 - Characteristics of the Notes
2017, May 02 - Characteristics of the Warrants

2017, June 07 - 2016 Annual Report - statutory
2017, April 30 - 2016 Annual Report - non statutory

2016, December 07 - 2015 NOXXON Pharma N.V. IFRS

2016, October 31 - Condensed consolidated interim financial statements as of 30 June 2016

2016, September 28 - Information Document